HOPA Virtual Practice Management Series
Designed to Keep Practice Managers, Managing Their Practice
What if you could get practice management learning without leaving your practice for the day? Now you can! HOPA’s Virtual Practice Management (PM) Series will bring educational content and continuing education (CE) credits to you four times a year!
Our Virtual Practice Management Series:
- Provides single-topic, 60-90-minute webinars
- Makes live CE credits available more frequently
- Creates a consistent flow of timely practice management learning
- Removes travel, time off, and cost barriers of in-person learning
Q4 Virtual Practice Management info
"Optimizing Oncology Stewardship: Inpatient Medication Restriction, Site-of-Care Transitions, and Cost-Containment Strategies"
- Tuesday, November 11, 2025 at 2-3:15 p.m. CT, via Zoom
- Cost: $25 for members, $33 for non-members
Session description
This session will equip clinical pharmacists, pharmacy leaders, and interdisciplinary oncology professionals with the tools to build or enhance oncology stewardship programs focused on medication restriction and transitions to lower-acuity care settings. As oncology therapeutics become increasingly complex and costly, thoughtful formulary management and care delivery optimization are more critical than ever. Participants will explore evidence-based strategies to design inpatient restriction criteria, track and evaluate medication use requests, and identify therapies suitable for ambulatory administration. In addition, the session will address how to leverage the Pharmacy and Therapeutics (P&T) Committee, clinical decision support tools, and the electronic health record (EHR) to improve visibility, safety, and resource stewardship. Case studies will highlight collaborative approaches and outcomes from stewardship initiatives that balance clinical value and financial sustainability across care settings.
Learning objectives
- Define the principles of oncology stewardship and the role of pharmacists in guiding formulary optimization, cost containment, and site-of-care transitions
- Recognize evidence-based criteria and policy frameworks to leverage multidisciplinary collaboration and P&T oversight for restricting inpatient oncology medications based on safety, efficacy, value, and care setting
- Design and implement tracking mechanisms and clinical decision support tools within the EHR to monitor restricted medication use, inform P&T decision-makers, and identify re-education opportunities
- Enhance stewardship program outcomes and operational efficiency by identifying cancer-directed therapies and supportive medications appropriate for safe administration in lower-acuity or outpatient settings
There will be 1.25 ACPE CE credit available for this session.
Meet our presenters
Emilie Aschenbrenner, PharmD, BCOP
Emilie Aschenbrenner is a Board Certified Oncology Pharmacist who specializes in Malignant Hematology, Blood and Marrow Transplant and Cellular Therapy. She is currently the Hematology Clinical Coordinator for Froedtert and the Medical College of Wisconsin, and supports the program through the development of institutional guidelines and operational pathways for novel immune therapies. She serves as a lead preceptor for pharmacy residents and is a guest faculty member at the Medical College of Wisconsin School of Pharmacy.
Kevin Krueger, PharmD, MBC, MHA
Kevin Krueger is the Director of Pharmacy, Oncology Services at Froedtert and the Medical College of Wisconsin. After finishing his residency at Froedtert, Kevin joined the Massachusetts General Hospital pharmacy team, where he was the pharmacy operations manager of compounding services and PGY2 Health-System Pharmacy Administration and Leadership residency program coordinator. Later, Kevin rejoined the Froedtert team as the pharmacy operation manager of oncology and infusion services. During this time, Kevin helped lead numerous cleanroom construction projects and provided oversight of eight IV cleanrooms at five infusion centers.
Janine Martino, PharmD, BCOP, APh
Janine Martino is a blood and marrow transplant and immune effector cell therapy specialist pharmacist at UC San Diego Health. Dr. Martino is an affiliate faculty member at the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. She co-chairs the UC San Diego IRB committee, coordinates the Oncology Pharmacy and Therapeutics Committee, and leads multiple initiatives in chemotherapy stewardship, contributing to the advancement of safe and effective cancer care practices.
Elizabeth Weil, PharmD, BCOP
Elizabeth Weil has been practicing for more than 10 years in oncology and has been an oncology clinical coordinator for almost two years. In her current role as solid tumor line coordinator at a large academic institution, the first project Weil tackled was the development of a formal restricted medication guideline and tracking process to continually evaluate requests and improvements. Weil has participated in the development of processes to safely administer HD MTX and bispecific medications to the ambulatory setting.
Future Virtual Practice Management sessions
Q1 2026 - "Bridging the Gap: Managing the Transitions of Care for Complex Therapies"
- Tuesday, March 3, 2026, at 2 p.m. CST
Q2-4 2026
- Topics and times to be determined
Are you well-versed in practice management but new to presenting live education? Virtual PM webinars are a great place to get started as a subject matter expert! Stay tuned for open calls for the rest of the 2026 Virtual Practice Management schedule.
Questions? Contact the HOPA Education team at education@hoparx.org.
Founding Sponsor
We would like to acknowledge Genentech as the Founding Sponsor of our 2024-2025 Virtual Practice Management Series. Thank you for your valued support!
